Skip to Content

Join the 'Hylaform Plus' group to help and get support from people like you.

Hylaform Plus News

FDA Medwatch Alert: Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication - Risk of Serious Patient Injury

Posted 1 Jun 2015 by Drugs.com

[Posted 05/28/2015] ISSUE: The FDA has reviewed information that suggests unintentional injection of soft tissue fillers into blood vessels in the face can result in rare, but serious side effects. Unintentional injection can block blood vessels and restrict blood supply to tissues. Sometimes this can result in embolization. This means the filler material has traveled to other parts of the ...

Choose Wrinkle Treatments Wisely, FDA Advises

Posted 14 Aug 2014 by Drugs.com

THURSDAY, Aug. 14, 2014 – Injectable dermal fillers are widely used by people seeking to smooth out wrinkles, but it's important to know the risks of these products before using them, a U.S. government expert says. Dermal fillers use a variety of materials to treat facial wrinkles. Most of these products are temporary and last for about six months or more. Only one permanent wrinkle filler is ...

FDA Medwatch Alert: Expression Injectable by Enhancement Medical: FDA Safety Communication - Adverse Events Associated with Unapproved Use As a Dermal Filler

Posted 7 Aug 2014 by Drugs.com

ISSUE: The FDA has become aware of adverse events associated with the unapproved use of the Expression product, hyaluronic acid that is packaged in a syringe, as a dermal filler. Events have included swelling, tenderness, firmness, lumps, bumps, bruising, pain, redness, discoloration, itching, and the development of hard nodules. BACKGROUND: Expression is listed with the FDA as an intranasal ...

Ask a Question

Further Information

Related Condition Support Groups

Facial Wrinkles

Hylaform Plus Patient Information at Drugs.com